News

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...
Researchers at Tohoku University have discovered that an oral drug called MA-5 can improve both heart and muscle problems in ...
Researchers at Tohoku University have discovered that an oral drug called MA-5 can improve both heart and muscle problems in ...
With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...
Barth syndrome is a rare genetic disorder with no known cure. Researchers at Tohoku University examined a new oral drug called MA-5 that could provide life-changing relief to these young patients.
It's the only drug for Barth Syndrome clinical trials. After several delays, however, the FDA announced it will not be approving the drug application.